Your browser doesn't support javascript.
Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children.
Chow, Eric J; Englund, Janet A.
  • Chow EJ; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, 1959 NE Pacific Street, Box 356423, Seattle, WA 98195, USA. Electronic address: ejchow@uw.edu.
  • Englund JA; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Washington, Seattle Children's Research Institute, 4800 Sand Point Way NE - MA7.234, Seattle, WA 98105, USA.
Infect Dis Clin North Am ; 36(2): 435-479, 2022 06.
Article in English | MEDLINE | ID: covidwho-2130982
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in children generally have milder presentations, but severe disease can occur in all ages. MIS-C and persistent post-acute COVID-19 symptoms can be experienced by children with previous infection and emphasize the need for infection prevention. Optimal treatment for COVID-19 is not known, and clinical trials should include children to guide therapy. Vaccines are the best tool at preventing infection and severe outcomes of COVID-19. Children suffered disproportionately during the pandemic not only from SARS-CoV-2 infection but because of disruptions to daily life, access to primary care, and worsening income inequalities.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Topics: Long Covid / Vaccines Limits: Child / Humans Language: English Journal: Infect Dis Clin North Am Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Topics: Long Covid / Vaccines Limits: Child / Humans Language: English Journal: Infect Dis Clin North Am Journal subject: Communicable Diseases Year: 2022 Document Type: Article